Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NanoPac in Lung Cancer
NCT04314895Phase 2Completed
- Sponsor
- NanOlogy
- Start
- Apr 2021
- Primary completion
- Sep 2023
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of NanoPac in lung cancer, sponsored by NanOlogy. Started Apr 2021; status: completed.
02
Drugs
NanoPac
03
Conditions
lung cancer
Beyond the preview
Go deeper on NCT04314895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04314895.